Virax Biolabs Group Ltd
NASDAQ:VRAX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Virax Biolabs Group Ltd
NASDAQ:VRAX
|
UK |
|
Thomas Cook (India) Ltd
NSE:THOMASCOOK
|
IN |
|
Assure Holdings Corp
OTC:IONM
|
US |
Bankruptcy Probability
Virax Biolabs Group Ltd's probability of bankruptcy is 2.6%, pointing to a small but noticeable default risk. The solvency score is 57/100 — a warning sign of potential financial weakness.
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Virax Biolabs Group Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
V
|
Virax Biolabs Group Ltd
NASDAQ:VRAX
|
1.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
108.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
63.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
64.7B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.3B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.3B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Virax Biolabs Group Ltd's probability of bankruptcy is 2.6%, pointing to a small but noticeable default risk.
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Virax Biolabs Group Ltd has total debt of 471.6k USD. This includes both short-term (195.6k USD) and long-term (276k USD) debt.
You can find a full breakdown on its Balance Sheet.
